FDA 510(k) review is due tomorrow. The Company has now provided the FDA a restatement of their response for additional information as of January 23, 2019, which the FDA has confirmed received. The FDA will now have 31 days to complete the 510(k) review of CardioComm's restated submission.
January 23 + 31 days = February 24 (saturday) that's why the company is halted today. I don't expect any bad news :)
Been a shareholder in this company for almost 7 years, always believe in the potential of this company and their products. This is an exciting moment for all shareholders. It will be an atomic bomb .